A Study of ZN-c5 and Abemaciclib in Participants With Breast Cancer

NCT04514159 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: ZN-c5
DRUG: Abemaciclib

Sponsor

Zeno Alpha Inc.